ArticlePotential Tyrosine Kinase Inhibitor Therapy Discontinuation for Patients With Chronic Myeloid Leukemia in a VA Regional NetworkAuthor:David Huberman, PhDPublish date: May 8, 2026Chronic myeloid leukemia (CML) is a hematologic malignancy resulting from an acquired mutation.Read More
